JBM-TC4

· Joben Bio-Medical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JBM-TC4, covering 2016-06-15 to 2016-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients [Phase 2]